BLO — Cannabix Technologies Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro CapFalling Star
- CA$38.81m
- CA$31.52m
- 63
- 16
- 21
- 24
Annual income statement for Cannabix Technologies, fiscal year end - April 30th, CAD millions except per share, conversion factor applied.
2018 April 30th | 2019 April 30th | 2020 April 30th | 2021 April 30th | 2022 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1.47 | 4.02 | 7.08 | 9.31 | 3.4 |
| Operating Profit | -1.47 | -4.02 | -7.08 | -9.31 | -3.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -1.47 | -3.88 | -6.97 | -9.24 | -3.37 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.47 | -3.88 | -6.97 | -9.24 | -3.37 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.47 | -3.88 | -6.97 | -9.24 | -3.37 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.47 | -3.88 | -6.97 | -9.24 | -3.37 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.016 | -0.038 | -0.029 | -0.086 | -0.03 |
| Dividends per Share |